President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentmyJoslin | Patient PortalAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Obstructive Sleep Apnea and the Cardiometabolic Syndrome: Clinical Perspectives and Interrelationships

Activity Description

CME Release Date: 1/14/2011
CME Expiration Date: 3/9/2013

This activity is supported by an educational grant from the ResMed Foundation.

Statement of Need

Recognition of the relationship between obstructive sleep apnea (OSA) and the cardiometabolic syndrome, and hence cardiovascular disease, is a recent development. There is evidence that OSA symptoms such as habitual snoring are associated with reduced glucose tolerance, hyperinsulinemia, type 2 diabetes, and the cardiometabolic syndrome, and that treatment of OSA can have beneficial impacts on insulin sensitivity and other aspects of metabolism as well as on the patient's quality of life. To help primary care providers offer optimal care and reduce cardiovascular risk in their patients, this symposium will teach you to recognize the sometimes subtle, nonspecific symptoms and clinical presentation of obstructive sleep apnea, and why you should refer both patients with suspected OSA and patients with cardiometabolic syndrome to a sleep specialist for evaluation and intervention.

Target Audience

  • Primary audience: Primary care providers; sleep specialists
  • Secondary audience: Diabetes/endocrinology and cardiology specialists (MD, DO, ANP, PA); primary care office staff

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the clinical manifestations of obstructive sleep apnea (OSA) and the indications for further clinical evaluation
  • Describe the methods to evaluate symptoms of OSA and to confirm the diagnosis
  • Explain the treatment options for OSA, as well as the indications for further evaluation of patients with OSA for components of the cardiometabolic syndrome
  • List the components of the cardiometabolic syndrome and how this syndrome relates to increased cardiovascular risk
  • Describe the clinical interrelationship between OSA and the components of the cardiometabolic syndrome

Faculty and Disclosures

Osama Hamdy, MD, PhD, FACE*
Assistant Professor of Medicine
Harvard Medical School
Medical Director, Obesity Clinical Program
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Hamdy is on the speakers bureau for Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Novo Nordisk Inc., and Takeda Pharmaceuticals North America, Inc.

Melanie Pogach, MD
Instructor in Medicine
Harvard Medical School
Assistant Sleep Medicine Fellowship Director
Beth Israel Deaconess Medical Center
Boston, MA

Disclosure: Dr. Pogach has no relevant financial relationships

*Also on the CME Advisory Committee

Planning Committee:

Richard S. Beaser, MD*
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director, Professional Education
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Beaser is a consultant for CeQur Ltd.

Julie A. Brown*
Director
Professional Education
Joslin Diabetes Center
Boston, MA

Disclosure: Ms. Brown has no relevant financial relationships.

Karen J. Kuc*
Assistant Director
Professional Education
Joslin Diabetes Center
Boston, MA

Disclosure: Ms. Kuc has no relevant financial relationships.

James Neighbours, MEd*
Associate Director
Education Design and Outcomes
Professional Education
Joslin Diabetes Center
Boston, MA

Disclosure: Mr. Neighbours has no relevant financial relationships.

Jonathan Scoble*
Grants Manager
Professional Education
Joslin Diabetes Center
Boston, Ma

Disclosure: Mr. Scoble has no relevant financial relationships.

Kenneth J. Snow, MD, MBA*
Director, Medical Programs, Strategic Initiatives
Senior Physician
Adult Diabetes Section
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Snow has no relevant financial relationships.

*Also on the CME Advisory Committee


CME Advisory Committee

Enrique Caballero, MD
Director, Medical Affairs
Professional Education
Director, Latino Diabetes Initiative
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Enrique Caballero is a consultant and on the speakers bureau and scientific advisory board for Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., and Eli Lilly and Company.

Jerry Cavallerano, OD, PhD
Optometrist
Beetham Eye Institute
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Jerry Cavallerano has no relevant financial relationships.

A. Patrick Egan, MD
Family Practice
Internal Medicine Specialist
Dorchester House Multi-Service Center
Boston, MA

Disclosure: Dr. A. Patrick Egan has no relevant financial relationships.

Ann E. Goebel-Fabbri, PhD
Instructor in Psychiatry
Harvard Medical School
Psychologist
Behavioral and Mental Health Unit
Joslin Diabetes Center
Boston, MA

Disclosure: Anne E. Goebel-Fabbri has no relevant financial relationships.

Robert C. Stanton, MD
Associate Professor of Medicine
Harvard Medical School
Chief of Nephrology
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Robert C. Stanton has no relevant financial relationships.

Howard A. Wolpert, MD
Assistant Professor of Medicine
Harvard Medical School
Director, Insulin Pump Program
Senior Physician
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Howard A. Wolpert is a consultant for Abbott Diabetes Care; Becton, Dickinson and Company; Insulet Corporation; and Novo Nordisk, Inc.

Accreditation and Designation of Credit

The Joslin Diabetes Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits.TM Physicians should only claim credit commensurate with the extent of their participation in the activity.

This CME activity was planned and produced in accordance with ACCME Essentials.

Participants not eligible for continuing medical education credit will receive a certificate of participation.


Estimated Time to Complete Activity: 1 hour

Computer Requirements

To participate in this activity, your computer will need the following hardware and software:

Credit Instructions

How to Obtain Credit:

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. Study the educational content online.
  3. Complete the online postest and evaluation.
  4. Physicians who receive a grade of 70% or better on the posttest and complete the evaluation will receive immediate CME credit.
  5. All other participants who receive a grade of 70% or better on the posttest and who complete the evaluation will receive a certificate of participation.

Questions About This Activity

For questions regarding the content of this activity, contact the accredited provider for this CME activity: cme@joslin.harvard.edu

Start Now

Page last updated: October 31, 2014